28
Participants
Start Date
October 12, 2020
Primary Completion Date
February 6, 2022
Study Completion Date
March 2, 2022
Duvelisib
-For patients unable to administer orally, a duvelisib suspension will be administered through a nasogastric/orogastric tube.
Peripheral blood draw
"* First 10 patients enrolled~* Screening, Day 2, Day 4, Day 8, Day 10, Day 15, and Day 29"
Placebo
-Provided by Verastem
Washington University School of Medicine, St Louis
Verastem, Inc.
INDUSTRY
Washington University School of Medicine
OTHER